Philip Johnson Selected Research

OGT 719

1/2004

A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip Johnson Research Topics

Disease

21	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2004
5	Neoplasms (Cancer) 10/2022 - 11/2010
5	Liver Neoplasms (Liver Cancer) 02/2017 - 01/2004
2	Liver Failure 01/2019 - 06/2013
2	Pathologic Constriction (Stenosis) 01/2018 - 01/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2009 - 02/2008
1	Infections 10/2021
1	Cholangiocarcinoma 09/2021
1	False Aneurysm (Pseudoaneurysm) 02/2019
1	HIV Infections (HIV Infection) 01/2019
1	Anorexia 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Neutropenia 01/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Hepatitis 02/2017
1	Thyroid Crisis (Thyrotoxic Crisis) 03/2016
1	Portal Hypertension 08/2015
1	Fibrosis (Cirrhosis) 08/2015
1	Sepsis (Septicemia) 05/2014
1	Critical Illness (Critically Ill) 05/2014
1	Drug-Related Side Effects and Adverse Reactions 01/2014
1	Peripheral Nerve Injuries 09/2013
1	Ascites 01/2013
1	Rhinosinusitis 09/2011
1	Pneumonia (Pneumonitis) 07/2011
1	Asthma (Bronchial Asthma) 08/2008
1	Dyspnea (Shortness of Breath) 02/2008
1	Carcinoid Tumor (Carcinoid) 08/2007
1	Hepatitis B 08/2004
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

8	Sorafenib (BAY 43-9006)FDA Link 10/2021 - 01/2009
7	BilirubinIBA 07/2019 - 08/2015
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2012
5	AlbuminsIBA 07/2019 - 10/2015
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2021 - 08/2004
2	Pharmaceutical PreparationsIBA 01/2014 - 02/2008
2	Albuterol (Salbutamol)FDA LinkGeneric 12/2009 - 08/2008
2	Tiotropium Bromide (Spiriva)FDA Link 12/2009 - 02/2008
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 12/2009 - 08/2008
2	Cholinergic Antagonists (Anticholinergics)IBA 08/2008 - 02/2008
1	Mitochondrial DNA (mtDNA)IBA 10/2022
1	Cell-Free Nucleic AcidsIBA 10/2022
1	Viral DNAIBA 10/2022
1	SirtuinsIBA 09/2021
1	Antiviral Agents (Antivirals)IBA 07/2021
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	thiamine triphosphorate (TTP)IBA 10/2019
1	lenvatinibIBA 07/2019
1	Tetanus Antitoxin FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	C-Reactive ProteinIBA 12/2017
1	AgglutininsIBA 10/2015
1	Prothrombin (Factor II)IBA 10/2015
1	Amino Acids FDA Link 05/2014
1	CitrullineIBA 05/2014
1	Local AnestheticsIBA 09/2013
1	Gentamicins (Gentamicin)FDA LinkGeneric 09/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2010
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 08/2008
1	Bronchodilator Agents (Bronchodilators)IBA 08/2008
1	PowdersIBA 02/2008
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2007
1	OGT 719IBA 01/2004
1	Asialoglycoprotein ReceptorIBA 01/2004
1	Topoisomerase I InhibitorsIBA 10/2002
1	Etoposide (VP 16)FDA LinkGeneric 10/2002
1	Topotecan (Hycamtin)FDA LinkGeneric 10/2002

Therapy/Procedure

10	Therapeutics 09/2021 - 04/2008
4	Drug Therapy (Chemotherapy) 09/2021 - 04/2008
2	Liver Transplantation 11/2018 - 01/2013
1	Radiotherapy 09/2021
1	Time-to-Treatment 07/2019
1	Cesarean Section (Caesarean Section) 02/2019
1	Intramuscular Injections 01/2019
1	Radiofrequency Ablation 06/2018
1	Catheters 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Intra-Arterial Infusions 06/2012
1	Extracorporeal Membrane Oxygenation 07/2011
1	Immunotherapy 04/2008